noscript

News and Announcements

Arthritis Relief Plus Annual Update 2016; US FDA Compliance Completed, Australian Government Support & First Commercial Batch in US

  • Published January 17, 2017 5:08PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Arthritis Relief Plus Ltd (ARP) attained countless achievements during 2016.

  • The company managed to complete US FDA compliance, securing an OTC topical drug status/ classification for 4Jointz.
  • With also securing Australian Government support in the first cohort at the Rocketspace LandingPad in San Francisco.
  • ARP also were awarded the Queensland Government Ignite grant, with commencing production of the first commercial batch of 4 Jointz in the USA.
  • ARP also received to its advantage, national and regional broadcasting news coverage of its product throughout Australia.
  • Finally, ARP secured a new investment offer which opened to fund the USA market growth and prepare for the global market partnering/licensing activities.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now